Just ask iiris
When you prescribe Xiidra, we want to make sure your patients get what they need—especially help verifying their benefits. What if they could call a number and get help from a real, live person? Just ask iiris—not just one person but a whole squad of special agents highly trained in helpfulness.
Your Xiidra coverage
Commercial insurance, government insurance, or no insurance at all? Your patients can ask iiris and we’ll help them verify their benefits and figure out their coverage.
Savings specialists, too
You know what else is our thing? Helping people save on their Xiidra prescription. If they’re eligible for any special offers or assistance programs, we’ll let them know. And we’ll help them sign up.
But wait, there’s more!
We can even grant your patients Xiidra iinsider® status for info, special offers, refill reminders, and more beamed to their inbox or phone. All they have to do is ask iiris. Monday through Friday, 9 am through 8 pm ET.Want to learn more?
Get Xiidra for $0
Commercially insured patients can get their first 30-day prescription free and then pay $10 every month for as long as they take Xiidra.* At that rate, patients may pay as little as $110 for one year, with no savings cap on the first prescription.
All they need to do is bring their Xiidra iinsider® card along with a valid 30-day prescription to the pharmacy.
Patients can check eligibility and sign up right here.
Questions? Call 1-844-694-47471-844-694-4747
*Eligible patients will receive their first 30-day prescription free and up to $250 savings for each 30-day refill. The actual savings on their out-of-pocket costs for Xiidra will vary according to personal health care insurance coverage. Program subject to change. Not available under federal or state programs. Patients can visit here for full details and restrictions.
Xiidra patient site >
All of the important info your patients want to know about Xiidra, all in one place.
Xiidra® (lifitegrast ophthalmic solution) 5% is indicated for the treatment of signs and symptoms of dry eye disease (DED).
Important Safety Information
In clinical trials, the most common adverse reactions reported in 5-25% of patients were instillation site irritation, dysgeusia and reduced visual acuity. Other adverse reactions reported in 1% to 5% of the patients were blurred vision, conjunctival hyperemia, eye irritation, headache, increased lacrimation, eye discharge, eye discomfort, eye pruritus and sinusitis.
To avoid the potential for eye injury or contamination of the solution, patients should not touch the tip of the single-use container to their eye or to any surface.
Contact lenses should be removed prior to the administration of Xiidra and may be reinserted 15 minutes following administration.
Safety and efficacy in pediatric patients below the age of 17 years have not been established.